Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia

被引:0
作者
Howard Chertkow
Howard H Feldman
Claudia Jacova
Fadi Massoud
机构
[1] McGill University,Department of Neurology and Neurosurgery
[2] Bloomfield Centre for Research in Aging,Division of Neurology
[3] Lady Davis Institute,Division of Neurology, Faculty of Medicine
[4] Faculty of Medicine,Department of Medicine
[5] University of British Columbia,undefined
[6] UBC Hospital,undefined
[7] University of British Columbia,undefined
[8] UBC Hospital,undefined
[9] Centre Hospitalier de l'Université de Montréal,undefined
来源
Alzheimer's Research & Therapy | / 5卷
关键词
Dementia; Mild Cognitive Impairment; Vascular Dementia; Structural Magnetic Resonance Imaging; International Working Group;
D O I
暂无
中图分类号
学科分类号
摘要
There have been several newly proposed sets of diagnostic criteria for Alzheimer's disease/mild cognitive impairment, advanced by the National Institute of Aging/Alzheimer's Association working groups in 2011 and by the International Working Group in 2007 and 2010. These sets each aim to provide broader disease stage coverage with incorporation of disease biomarkers into the diagnostic process. They have focused particular attention on the earlier identification of disease with focus on the preclinical and predementia stages. This paper reviews these diagnostic criteria and provides 2012 consensus recommendations from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia on their applications in both clinical and research settings.
引用
收藏
相关论文
共 327 条
[1]  
McKhann GM(2011)The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement 7 263-269
[2]  
Knopman DS(2011)The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup Alzheimers Dement 7 270-279
[3]  
Chertkow H(2011)Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement 7 280-292
[4]  
Hyman BT(2007)Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 734-746
[5]  
Jack CR(2010)Revising the definition of Alzheimer's disease: a new lexicon Lancet Neurol 9 1118-1127
[6]  
Kawas CH(2009)Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease Brain 132 1355-1365
[7]  
Klunk WE(2010)Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 119-128
[8]  
Koroshetz WJ(2011)Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2672-2713
[9]  
Manly JJ(1993)The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 2412-2414
[10]  
Mayeux R(2005)The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 695-699